[BidClub_]

PERSON DIRECTORY

Erik Torenberg

Erik Torenberg appears in 137 indexed conversations across The a16z Show, The Cognitive Revolution. This directory brings every appearance, source, TL;DR, digest, and transcript into one searchable feed.

137 EPISODES2 SHOWS
8 episodes3 active
Language
The a16z ShowEN · 54 min

How AI Is Reinventing Computing from Chips to Power

Ben HorowitzMartin CasadoRaghu RaghuramErik Torenberg

a16z’s new AI infrastructure fund captures a founder migration into hardware, with top-founder hardware pitches rising from roughly 3–5% to “north of 20% or 30%.”Hyperscaler capex, booked-out GPUs and resale premiums support opportunities across chips, power and cooling, while grid shortages, regulation and uncontrolled agent spending remain constraints.

The a16z ShowEN · 81 min

Marc Andreessen's 2026 Outlook: AI Timelines, US vs. China, and The Price of AI

Marc AndreessenErik Torenberg

Andreessen sees AI three years into an 80-year revolution, with customer revenue validating unusually rapid adoption across an already-built global distribution network.Falling token costs, competing chips, smaller models, and US-China rivalry could expand demand dramatically, while state regulation remains a major unresolved risk.

The Cognitive RevolutionEN · 115 min

AMA Part 1: Is Claude Code AGI? Are we in a bubble? Plus Live Player Analysis

Erik TorenbergNathan LabenzZvi MoshowitzGregEugenia KuydaAli BehrouzLogan KirkpatrickJungwon Hwang

AI’s strongest proof point is its performance alongside Nathan Labenz’s son’s oncologists, with minimal residual disease below one cell per million after remission before round two.Claude Opus 4.5 may be software AGI, but jagged failures and holiday hype leave full AGI unresolved, while context management, multi-model judgment, and infrastructure financing remain key risks.

The a16z ShowEN · 56 min

Faster Science, Better Drugs

Erik TorenbergPatrick HsuJorge Conde

Arc is combining neuroscience, immunology, machine learning, chemical biology, and genomics to reduce organizational and experimental latency, with virtual cells aimed at navigating diseased cells toward healthy states.The commercial prize depends on better targets, drug design, higher clinical success, lower capital intensity, and shorter timelines, but physical testing and human endpoints remain serial bottlenecks while virtual-cell capability sits somewhere between GPT-1 and GPT-2.

The a16z ShowEN · 56 min

Is Non-Consensus Investing Overrated?

Erik TorenbergMartín CasadoLeo Polovets

Martín Casado argues that ignoring consensus is dangerous because early venture markets are “pretty darn efficient,” while a startup dependent on follow-on capital must eventually become fundable.The highest-alpha bets may begin outside consensus and then reprice sharply, but rapid markups can create fragility; the unresolved test is whether high-priced winners actually produce superior venture returns or merely reflect price arbitrage.

The a16z ShowEN · 78 min

Steven Sinofsky & Balaji Srinivasan on the Future of M&A, AI & Tech

Erik TorenbergSteven SinofskyBalaji Srinivasan

Blocking Big Tech exits can starve startups of capital and strengthen incumbents: DOJ intervention in JetBlue’s acquisition of Spirit was followed by Spirit going bust, while acquisitions fund challengers through incumbent “surrenders.”AI’s platform shift is driving faster acqui-fires, including Google’s Windsurf deal, while copyright litigation, energy constraints and restrictions on Chinese models could squeeze US leadership.

The a16z ShowEN · 42 min

Building Cluely: The Viral AI Startup that raised $15M in 10 Weeks w/ Roy Lee

Erik TorenbergBryan KimRoy Lee

Cluely is testing whether distribution can discover product-market fit faster than conventional development, using more than 1 billion views and sales-call videos that Roy says generated over $1 million in enterprise revenue.Its translucent screen-and-audio overlay targets an emerging AI interface, while follower-based hiring and paid creator production industrialize acquisition; the unresolved risk is that technically simple features are copied before the land grab becomes durable.

The Cognitive RevolutionEN · 61 min

a16z on Protecting Little Tech: The Techno-Optimist AI Policy Agenda with Matt Perault

Erik TorenbergNathan LabenzMatt Perault

a16z favors policing harmful AI uses while keeping research broadly open, arguing that compute or training-cost thresholds could reinforce concentration among only three to 10 companies.The unresolved risk is whether ex-post enforcement can address irreversible harms, while temporary rules, liability regimes, and the Trump administration’s national AI action plan in June or July shape market access.